Literature DB >> 22526475

Normal QT dispersion in colchicine-resistant familial Mediterranean fever (FMF).

Udi Nussinovitch1, Avi Livneh, Benjamin Volovitz, Moshe Nussinovitch, Ilan Ben-Zvi, Merav Lidar, Naomi Nussinovitch.   

Abstract

The association between familial Mediterranean fever (FMF) and subclinical cardiac disease remains controversial. The aim of the current study was to evaluate whether FMF patients, who do not respond to colchicine treatment, and thereby endure persistent inflammation, have increased QT dispersion (QTd) values. Twenty-two FMF patients and 22 age- and sex-matched control subjects were included in the study. Repolarization and QT dispersion parameters were computed from 12-lead ECG recording using designated computer software, and results of five beats were subsequently averaged. Both FMF patients and controls had similar comorbidities, similar values of average QT, average corrected QT interval length, average QTd interval, average QT corrected dispersion, QT dispersion ratio, JT dispersion (JTd), and JT corrected dispersion. In conclusion, FMF patients who were unresponsive to colchicine treatment and did not develop amyloidosis had normal QTd and JTd parameters, indicating a non-increased risk for repolarization-associated ventricular arrhythmias.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22526475     DOI: 10.1007/s10067-012-1982-8

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  18 in total

1.  Spatial aspects of ventricular repolarization in postinfarction patients.

Authors:  P Dilaveris; E Gialafos; A Pantazis; A Synetos; F Triposkiadis; S Stamatelopoulos; J Gialafos
Journal:  Pacing Clin Electrophysiol       Date:  2001-02       Impact factor: 1.976

2.  QT and JT dispersion in children with long QT syndrome.

Authors:  M J Shah; T S Wieand; L A Rhodes; C I Berul; V L Vetter
Journal:  J Cardiovasc Electrophysiol       Date:  1997-06

3.  QT dispersion in uncomplicated familial Mediterranean fever.

Authors:  Naomi Nussinovitch; Avi Livneh; Keren Katz; Pnina Langevitz; Olga Feld; Moshe Nussinovitch; Benjamin Volovitz; Merav Lidar; Udi Nussinovitch
Journal:  Clin Rheumatol       Date:  2010-04-11       Impact factor: 2.980

4.  Q-T and JT dispersion in the elderly with urban hypothermia.

Authors:  Z Duraković; M Misigoj-Duraković; N Corović
Journal:  Int J Cardiol       Date:  2001 Sep-Oct       Impact factor: 4.164

5.  Prevalence of ischemic heart disease in patients with familial Mediterranean fever.

Authors:  P Langevitz; A Livneh; L Neumann; D Buskila; J Shemer; D Amolsky; M Pras
Journal:  Isr Med Assoc J       Date:  2001-01       Impact factor: 0.892

6.  Criteria for the diagnosis of familial Mediterranean fever.

Authors:  A Livneh; P Langevitz; D Zemer; N Zaks; S Kees; T Lidar; A Migdal; S Padeh; M Pras
Journal:  Arthritis Rheum       Date:  1997-10

7.  Are familial Mediterranean fever (FMF) patients at increased risk for atherosclerosis? Impaired endothelial function and increased intima media thickness are found in FMF.

Authors:  Ali Akdogan; Meral Calguneri; Bunyamin Yavuz; E Bengi Arslan; Umut Kalyoncu; Levent Sahiner; Omer Karadag; Ihsan Ertenli; Sedat Kiraz; Kudret Aytemir; Deniz Akata; Lale Tokgozoglu; Ali Oto
Journal:  J Am Coll Cardiol       Date:  2006-11-09       Impact factor: 24.094

8.  Heart rate variability in familial Mediterranean fever.

Authors:  Naomi Nussinovitch; Avi Livneh; Keren Katz; Pnina Langevitz; Olga Feld; Moshe Nussinovitch; Benjamin Volovitz; Merav Lidar; Udi Nussinovitch
Journal:  Rheumatol Int       Date:  2009-11-01       Impact factor: 2.631

9.  Assessment of atrial conduction time in patients with familial Mediterranean fever.

Authors:  Gurkan Acar; Ahmet Akcay; Mehmet Sayarlioglu; Abdullah Sokmen; Gulizar Sokmen; Sedat Koroglu; Mehmet Gunduz; Murat Ispiroglu; Cemal Tuncer
Journal:  Pacing Clin Electrophysiol       Date:  2009-03       Impact factor: 1.976

10.  Early ultrasonographic markers of atherosclerosis in patients with familial Mediterranean fever.

Authors:  Ismail Sari; Oguzhan Karaoglu; Gercek Can; Servet Akar; Aytac Gulcu; Merih Birlik; Nurullah Akkoc; Mehmet Tunca; Yigit Goktay; Fatos Onen
Journal:  Clin Rheumatol       Date:  2007-01-23       Impact factor: 3.650

View more
  8 in total

Review 1.  Familial Mediterranean fever: An updated review.

Authors:  İsmail Sarı; Merih Birlik; Timuçin Kasifoğlu
Journal:  Eur J Rheumatol       Date:  2014-03-01

2.  Cardiac autonomic functions in children with familial Mediterranean fever.

Authors:  Murat Şahin; Mustafa Kır; Balahan Makay; Pembe Keskinoğlu; Elçin Bora; Erbil Ünsal; Nurettin Ünal
Journal:  Clin Rheumatol       Date:  2014-06-15       Impact factor: 2.980

Review 3.  Cardiovascular disease in patients with autoinflammatory syndromes.

Authors:  Rainer Hintenberger; Agnes Falkinger; Kathrin Danninger; Herwig Pieringer
Journal:  Rheumatol Int       Date:  2017-11-01       Impact factor: 2.631

Review 4.  Cardiac disease in familial Mediterranean fever.

Authors:  Eren Erken; Ertugrul Erken
Journal:  Rheumatol Int       Date:  2017-10-20       Impact factor: 2.631

5.  QT Interval Derived Measurements in Patients with Cardiac Syndrome X Compared to Coronary Artery Disease.

Authors:  Mohamed F Lutfi
Journal:  Front Physiol       Date:  2016-09-21       Impact factor: 4.566

6.  Late ventricular potentials in familial Mediterranean fever with and without AA amyloidosis.

Authors:  Udi Nussinovitch; Avi Livneh
Journal:  Eur J Rheumatol       Date:  2017-09-01

Review 7.  Cardiovascular Sequelae and Genetics of Familial Mediterranean Fever: A Literature Review.

Authors:  Jahanzeb Malik; Asma Shabbir; Atif Nazir
Journal:  Pulse (Basel)       Date:  2021-06-03

8.  P wave dispersion and QT dispersion in adult Turkish migrants with familial mediterranean fever living in Germany.

Authors:  Arnd Giese; Ahmet Ornek; Mustafa Kurucay; Kaffer Kara; Helmut Wittkowski; Faekah Gohar; Bjoern A Menge; Wolfgang E Schmidt; Christoph Zeidler
Journal:  Int J Med Sci       Date:  2014-08-21       Impact factor: 3.738

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.